EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 67 filers reported holding EPIZYME INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $20,000 | -98.6% | 1,165 | -98.1% | 0.00% | -98.9% |
| Q2 2015 | $1,440,000 | -82.4% | 60,000 | -86.1% | 0.09% | -87.3% |
| Q4 2014 | $8,164,000 | +6.1% | 432,619 | +52.4% | 0.68% | -17.1% |
| Q3 2014 | $7,696,000 | +480.4% | 283,890 | +566.4% | 0.83% | +535.4% |
| Q2 2014 | $1,326,000 | +10.7% | 42,602 | -19.0% | 0.13% | +3.2% |
| Q1 2014 | $1,198,000 | +136.8% | 52,602 | +192.2% | 0.13% | +147.1% |
| Q2 2013 | $506,000 | – | 18,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |